Article
In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR-/-ApoB100/100 mice.
Diabetes & vascular disease research - 1 Jul 2018
Blanco Fabiana, Heinonen Suvi E, Gurzeler Erika, Berglund Lisa M, Dutius Andersson Anna-Maria, Kotova Olga, Jönsson-Rylander Ann-Cathrine, Ylä-Herttuala Seppo, Gomez Maria F
Abstract excerpt
AIMS: Despite vast clinical experience linking diabetes and atherosclerosis, the molecular mechanisms leading to accelerated vascular damage are still unclear. Here, we investigated the effects of nuclear factor of activated T-cells inhibition on plaque burden in a novel mouse model of type 2 diabetes that better replicates human disease. METHODS & RESULTS: IGF-II/LDLR-/-ApoB100/100 mice were generated by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
